MCM
SRDX

Matarin Capital Management’s Surmodics SRDX Stock Holding History

Matarin Capital Management’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-20,202
Closed -$786K – 215
2020
Q3 		$786K Sell
20,202
-2,207
-10% -$97K 0.16% 154
2020
Q2 		$969K Buy
+22,409
New +$848K 0.19% 147
2018
Q3 		– Sell
-9,337
Closed -$515K – 310
2018
Q2 		$515K Sell
9,337
-200
-2% -$9.24K 0.04% 250
2018
Q1 		$363K Sell
9,537
-845
-8% -$26.2K 0.03% 264
2017
Q4 		$291K Buy
10,382
+564
+6% +$17.2K 0.02% 274
2017
Q3 		$304K Buy
+9,818
New +$267K 0.03% 265

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Matarin Capital Management's SRDX Position: Q4 2020 in Review

Matarin Capital Management sold out of Surmodics (SRDX) in Q4 2020, closing a stake of 20,202 shares — an estimated $786K sold.

Matarin Capital Management first reported a position in SRDX in Q3 2017 and held it in 6 quarters. The position peaked at $969K in Q2 2020. 140 funds tracked by Wall St. Rank hold SRDX as of Q4 2020.

  • Matarin Capital Management reported no remaining Surmodics position as of Q4 2020 after selling out during the quarter.
  • Matarin Capital Management sold 20,202 Surmodics shares in Q4 2020, an estimated $786K.
  • Matarin Capital Management first reported a position in Surmodics in Q3 2017 and held it in 6 quarters.
  • Matarin Capital Management's Surmodics position peaked at $969K in Q2 2020.
  • 140 funds tracked by Wall St. Rank held Surmodics as of Q4 2020.

Based on Matarin Capital Management's 13F filing for Q4 2020, filed 3 Feb 2021.